Mama-Match
Invyncible review
Invyncible offers a first-time mom either cheaper compounded semaglutide ($192.50/mo against a $275.00 reference price) or tirzepatide ($210/mo against $300.00), or an FDA-approved Wegovy ($1,750/mo) or Zepbound ($1,540/mo) pen, on the same account — genuinely useful if your needs change — but it won't confirm your state's availability until you're already in the intake, and it discloses its corporate parent and street address rather than hiding behind a trade name, with a LegitScript seal displayed alongside them.
- HSA / FSA eligible
- Independently scored
- No insurance needed
Referral link, separate from the score
Every medical claim is cited to its primary source — the clinical trial or the FDA label — so you can open it and check it yourself. No one on this team is your healthcare professional. What follows is friendly information, never medical advice.
Gentler first steps than Invyncible
Providers we'd send a friend to, with the ones we work with listed first — CoreAge Rx leads our ranking on the score. Some of these links earn MamaGLP a referral commission.
- Meet CoreAge RxCoreAge RxOur #1 pick
The gentlest place to land if you're just starting out: one flat monthly price with no surprises, both medications in a single account, and an intake that walks you through it step by step instead of cornering you with a quiz.
- Meet ShedRx
A lot of support for the money — coaching, unlimited follow-ups and a full Spanish-language site, available in all 50 states except Puerto Rico — with one big catch: a two-month minimum commitment that cancelling early doesn't release you from.
- Meet Synergy Rx
Now confirmed to publish real GLP-1 prices — compounded semaglutide from $199, tirzepatide from $349, plus brand options — right on its products page, no consult required, contrary to what an earlier check found.
Invyncible at a glance
- Semaglutide
- $192.50/mo
- Tirzepatide
- $210/mo
- Coverage
- Not publicly disclosed; confirmed during intake
- Brand-name
- Yes
How we scored Invyncible
Each factor is judged from Invyncible's actual pricing, disclosures and support, then combined into the Mama-Match Score of 47/100 using the same weighted six-factor framework we apply to every provider — never influenced by whether a provider pays us.
The start feels transactional — more cash register than welcome.
The cost is unpredictable, hidden behind a quiz, or in the premium range.
Little public detail about who oversees your care, and how.
Coverage is limited or gated behind a signup.
Support is thin once the prescription ships.
Cancelling carries real friction — commitments, notice windows or non-refundable charges.
How we verified this review
- Last reviewed
- August 2026
- Confidence
- Medium
- Primary source
- www.invyncible.com/semaglutide-programs
Florida-based; discloses its corporate parent and street address, plus a LegitScript seal — more transparent than most compounded-only sites. Every price on its programs pages reads as a permanent 'sale' against a higher reference price rather than a limited-time promo, so the sale figure is recorded as the standing price since it's what the checkout flow actually uses. Sells both compounded programs and FDA-approved brand Wegovy/Zepbound on the same account. No state list published. No FDA warning letter found for Invyncible in a dedicated search or WLR's consolidated enforcement index.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $192.5 | Standard FormulaPriced at $192.50 against a $275.00 reference figure. Add-on Glycine/B12 tiers run $149–$262.50/mo; brand-name Wegovy is sold direct at $1,750/mo (vs. $2,500 list). |
| Compounded tirzepatide | $210 | Standard FormulaPriced at $210.00 against a $300.00 reference figure. Add-on tiers run $180–$260/mo; brand-name Zepbound is sold direct at $1,540/mo (vs. $2,200 list). |
Swipe the table to see plan details →
HSA/FSA is usually accepted for GLP-1 telehealth — check your plan. Prices reflect what Invyncible disclosed publicly at our last review and change often; confirm the current number on Invyncible's site.
What we like
- Discloses its corporate parent and a physical address instead of hiding behind a brand name
- LegitScript-verified
- Both compounded programs and FDA-approved Wegovy/Zepbound on the same account
- No long-term commitment; cancel anytime per its own FAQ
The caveats
- No state-availability list — confirmed only during intake
- Every price is shown as a permanent 'sale' against a higher reference figure that never seems to actually apply
- Brand-name pricing ($1,540–$1,750/mo) still runs well above most insurance-covered options
- Nothing on the site addresses pregnancy or the right timing for breastfeeding
Invyncible for moms: our verdict
Invyncible offers a first-time mom either cheaper compounded semaglutide ($192.50/mo against a $275.00 reference price) or tirzepatide ($210/mo against $300.00), or an FDA-approved Wegovy ($1,750/mo) or Zepbound ($1,540/mo) pen, on the same account — genuinely useful if your needs change — but it won't confirm your state's availability until you're already in the intake, and it discloses its corporate parent and street address rather than hiding behind a trade name, with a LegitScript seal displayed alongside them. It runs about $192.5/mo.
We looked at Invyncible the way moms actually have to: not just the monthly cost, but the right timing around pregnancy and nursing and honest, clear pricing from the start — the parts a generic weight-loss review skips.
What Invyncible actually costs
- Compounded semaglutide — Standard Formula: $192.5/mo
- Compounded tirzepatide — Standard Formula: $210/mo
That's roughly in line with our list's median of ~$172/mo.
The medications Invyncible prescribes
Invyncible prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss results, and having both on one account matters when insulin resistance (common with PCOS and after gestational diabetes) makes tirzepatide the better fit. It can point you toward FDA-approved brand-name pens as well as the compounded versions — approved products carry the manufacturer's own pregnancy and breastfeeding label, which is cleaner to hand to an OB-GYN.
Where Invyncible fits — and where it doesn't — for moms
A good fit if…
- you may need to switch between semaglutide and tirzepatide as your body and your hormones change.
Look elsewhere if…
- you'd rather have a clinician talk the timing through with you, with the right timing around pregnancy and nursing in mind — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety and oversight
Our confidence is moderate — the core data holds up, but some details (state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing moms can do is confirm which licensed pharmacy fills the prescription and what's in the formula — we explain how we score oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is proven safe during pregnancy or breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the decision about timing is yours and your healthcare provider's.
The bottom line
Invyncible is a reasonable option — weigh it on the right timing around pregnancy and nursing and honest, clear pricing from the start against the alternatives below. For most moms, CoreAge Rx is still the best choice overall — see why it tops our ranking.
The bottom line
Best for: A mom who wants the option to start compounded and later move to a brand-name pen without switching providers.
Keep comparing Invyncible
Head-to-heads and alternatives
Ranked boards
- Best GLP-1 for moms — a gentle first step
- Best GLP-1 for women — PCOS, cycles, perimenopause
- Best GLP-1 for first-timers (easiest to start)
- Most affordable GLP-1 with honest, clear pricing
- Best semaglutide for mothers — price and practicality
- Best semaglutide for women — compounded vs brand
- Best semaglutide for young moms — postpartum and budget
- Best tirzepatide for mothers — is it worth the extra
- Best tirzepatide for women — PCOS and insulin resistance
- Best GLP-1 with bilingual / Spanish-language support
Invyncible, answered
- How much does Invyncible cost?
- As of our last review, Invyncible's compounded pricing starts around $192.5/mo ($192.50/mo semaglutide, $210/mo tirzepatide). Confirm the current all-in price on Invyncible's site before you commit.
- Is Invyncible safe to use while breastfeeding?
- Here is the honest answer: no GLP-1 — compounded or brand-name — is established as safe during pregnancy or breastfeeding, and the labels advise against use; Invyncible is no exception. Plan any GLP-1 for after weaning, and talk the timing through with your own clinician.
- Does Invyncible offer both semaglutide and tirzepatide?
- Yes — Invyncible offers both. Tirzepatide's dual action is often preferred when insulin resistance is driving the weight, which matters with PCOS and after gestational diabetes.
- Where does Invyncible land in your ranking?
- Invyncible scores 47/100 on our Mama-Match Score (rank #117), which weights six things that matter to a first-timer. Our #1 pick, CoreAge Rx, leads the ranking — see how they compare.
Prices, states and verification reflect what Invyncible disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the published methodology. This is gentle background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.